The PRESBYLENS™ Corneal Inlay (CI) is a unique, patented refractive surgery solution that is designed to correct vision lost by the natural aging process called presbyopia.
The PRESBYLENS™ CI, made from our proprietary microporous hydrogel material, is designed to be removable, adjustable and improve near vision with little or no compromise at distance.
The potential result is a significantly less risky and better-suited treatment of presbyopia than subtractive technologies such as LASIK.
ReVision Optics™, Inc., is a privately held corporation headquartered in Southern California.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 04/01/07 | Series D | 25M | Unknown |
People
Audrey Munnerlyn (VP Regulatory & Quality Affairs)
Brian Hovey (Board Member)
Randy Alexander (President/CEO)
Louis Bunn (CFO)
Ali Dahi (VP Process Development)
News
Canaan Partners promotes Wende Hutton to general partner
May 16, 2007 1:43 pm
Canaan Partners, a Silicon Valley venture capital firm, said it has promoted Wende Hutton to general partner. Hutton joined Canaan… Continue reading ⟩